INTRODUCTION
The endogenous inhibitor of apoptosis protein Survivin regulates apoptosis, cell division and cell cycle [1] [2] [3] and deregulated expression of Survivin is frequently observed in solid tumors and in leukemia cells. 4, 5 Survivin is the fourth most highly expressed transcript in cancer cells, 6 where its expression is commonly associated with a higher proliferative index, reduced apoptosis, resistance to chemotherapy and an increased rate of tumor recurrence. Although early studies suggested that Survivin was expressed only during development and in neoplastic adult cells, it is now known that Survivin is expressed in normal tissues, including hematopoietic stem and progenitor cells, 7, 8 T cells, [9] [10] [11] neutrophils, 12 erythroid cells 13 and vascular endothelial cells. 14, 15 In addition to its role during development, Survivin plays physiologic roles in proliferation and cell cycle control in mice and humans, particularly in highly proliferating cell systems such as hematopoiesis. Despite a better understanding of where and when Survivin is expressed, little is currently known about the mechanism of action of Survivin in normal adult cells or the growth and proliferative pathways in which it participates. We found that Survivin was highly expressed in primitive mouse hematopoietic stem cells (HSCs) and conditional deletion caused hematopoietic collapse. To gain insight into Survivin function in hematopoiesis, particularly in HSCs, we performed differential mRNA microarray analysis on mouse HSCs shortly following conditional Survivin deletion. Survivin deletion was associated with a significant reduction in the expression of the transcription factor Evi-1 and its downstream target genes Gata2, Pbx1 and Sall2, transcription factors critical for normal hematopoiesis. Ectopic expression of Evi-1 in HSCs significantly rescued the hematopoietic collapse due to the loss of Survivin in vivo. These studies provide the first mechanistic insight of the role of Survivin in regulating genetic pathways required for HSC function.
MATERIALS AND METHODS Animals
Tamoxifen. Mx1-Cre Survivin fl/fl mice received 3 injections of 260 mg/mouse polyI:polyC (GE HealthCare Bioscience, Piscataway, NJ, USA) intraperitoneally every other day (days 1, 3 and 5) and analyzed 14 days later. Red blood cells, platelets and the absolute neutrophil count were quantified using a Hemavet 950F hematology analyzer (Drew Scientific, Oxford, CT, USA). Total nucleated cellularity was quantitated and marrow or spleen hematopoietic stem and progenitor cells analyzed using flow cytometry and colony forming cell (CFC) analysis. For CFC analysis, cells were cultured in methylcellulose medium containing growth factors as previously described. 18 Colonies were scored after 7 days.
Retrovirus transduction and competitive HSC transplants
Bone marrow cells from Cre-Survivin fl/fl and Survivin fl/fl mice were transduced with ecotropic retrovirus generated using Phoenix Eco cells and MSCV( À ) or mouse Evi-1 complementary DNA (cDNA). Briefly, lineage-depleted marrow cells were prestimulated with 100 ng/ml of rhTpo, rmSCF and rhFL for 48 h and were then infected with fresh retrovirus supernatant containing MSCV( À ) or MSCV-Evi-1 19 for 2 consecutive days. Transduced marrow cells from Cre ER -Survivin fl/fl and Survivin fl/fl mice were cultured in Iscove's modified Dulbecco's medium/ 10% fetal bovine serum with 100 ng/ml of rhTpo, rmSCF and rhFL in the presence of 1 mM of 4OH-Tamoxifen (Sigma-Aldrich) for 7 days. Viable cells were enumerated by Trypan blue exclusion and stained with antibodies against c-kit, Sca-1, lineage markers and CD34.
For competitive transplantation assays, bone marrow cells from untreated Mx1-Cre Survivin fl/fl and Survivin fl/fl mice (CD45.2) were mixed with bone marrow cells from B6.BoyJ mice (CD45.1) and 1 Â 10 6 cells transplanted into lethally irradiated (1050 cGy) C57Bl/6 mice (CD45.2). Transduced cells (CD45.2) were cultured in Iscove's modified Dulbecco's medium/10% fetal bovine serum with 100 ng/ml of rhTpo, rmSCF and rhFL for 48 h, mixed with CD45.1 competitor bone marrow cells and 1 Â 10 6 cells transplanted into lethally irradiated (1050 cGy) C57Bl/6 mice (CD45.2). At 8 weeks post transplantation, Survivin gene deletion was induced as described above. The proportion of CD45.1 and CD45.2 cells in peripheral blood was determined monthly by flow cytometry.
The cDNA microarray and quantitative reverse transcriptase-PCR (RT-PCR) Bone marrow cells were harvested from control Survivin fl/fl and Cre ER -Survivin fl/fl mice at 14 days post Survivin gene deletion, stained with anti-CD34, c-kit, Sca-1 and lineage markers, and CD34 neg KSL cells were isolated by fluorescence-activated cell sorting (FACS). Sorted cells were immediately lysed and subjected to differential mRNA microarray analysis that was performed by Miltenyi Biotec. Briefly, 250 ng of each cDNA was used as a template for Cy3 and Cy5 labeling. Equal amounts of corresponding Cy3-and Cy5-labeled cDNAs from Tamoxifen-treated Survivin fl/fl and Cre ER -Survivin fl/fl mice were combined and hybridized overnight (17 h, 65 1C) to Agilent Whole Mouse Genome Oligo Microarrays (44 K) . Fluorescence signals of the hybridized microarrays were detected using Agilent's DNA microarray scanner (Agilent, Palo Alto, CA, USA). The Agilent Feature Extraction Software (FES) was used to determine feature intensities and ratios (including background subtraction and normalization), reject outliers and calculate statistical confidences (P-values). The differentially expressed genes were functionally classified according to their molecular function and role in biological processes, as defined by Gene Ontology (http://www.geneontology.org/) or the molecular pathways defined by the KEGG (Kyoto Encyclopedia of Genes and Genomes) database (http://www.genome.jp/kegg/) using the DAVID program (the Database for Annotation, Visualization and Integrated Discovery; http://david.abcc. ncifcrf.gov/home.jsp). 20 The pathways and the molecular network regulated by Survivin were visualized using Cytoscape software (http:// www.cytoscape.org/). 21 In separate experiments, total RNA isolated from the sorted control and Survivin-deleted CD34 neg KSL cells was used for quantitative RT-PCR using platinum SYBR Green qPCR SuperMix UDG (Invitrogen, Carlsbad, CA, USA). Primers for the RT-PCR experiments are listed in Supplementary Table 1 . Differences in mRNA were calculated using the D CT method and were normalized to HPRT, as previously described. 7 
Statistics
The data are expressed as mean ± s.e.m. Statistical differences between single agents and the control were determined using the two-tailed Student's t-test in Microsoft Excel (Microsoft Corp., Seattle, WA, USA).
The correlation of gene expression with Survivin was determined by Pearson's correlation analysis using Microsoft Excel.
RESULTS

Survivin is expressed in mouse HSCs and disruption impairs hematopoiesis
We previously demonstrated that Survivin is expressed in the human CD34 þ cell population that contains HSCs, 7, 22 and is critical for CD34 þ cell proliferation and survival. 7, 8, 23 It was also shown that Survivin deletion in mice impairs hematopoiesis. 17 However, the expression of Survivin in primitive mouse HSCs and the consequences of Survivin deletion on HSC function have not been studied. We now show using RT-PCR analysis that mouse Survivin mRNA is expressed in the CD34 neg KSL cell population that is enriched for long-term repopulating HSCs and in the KSL cell population that contains HSCs and hematopoietic progenitor cells (Figure 1a , upper panel). In addition, the mouse Survivin-121 splice variant that also demonstrates antiapoptotic activity 24 was also expressed in mouse HSCs and hematopoietic progenitor cells, but at significantly lower levels compared with full-length Survivin (Figure 1a , lower panel). Consistent with the high expression of Survivin in CD34 neg KSL cells, analysis of the public gene expression profile database GSE 4332 (www.ncbi.nlm.nih.gov/geo) showed that the Survivin signal was similarly expressed in mouse bone marrow Flt3 (CD135) neg CD34 neg KSL cells highly enriched for primitive HSCs 25 (Figure 1b ). Survivin was also detected in CD34 pos KSL cells that represent proliferating hematopoietic progenitor cells, consistent with our previous demonstration of Survivin upregulation during cell cycle. 7, 8 Peripheral blood white blood cells, red blood cells, marrow and spleen cellularity or the proportion or total number of lineagecommitted cells (Gr-1 þ , Mac-1 þ , B220 þ , CD4 þ and CD8 þ ) in the bone marrow or peripheral blood of Cre ER -Survivin fl/fl mice were within normal ranges at 14 days after Survivin deletion with the exception of a significant reduction in platelet count ( Table 1 ). In contrast, Survivin deletion significantly decreased the frequency and the absolute number of primitive CD34 neg KSL cells containing HSCs (61 ± 5% reduction compared with Survivin fl/fl mice receiving the same treatment; Figures 1c and d, left panel) and also reduced total bone marrow lin neg cells (37±6%), KL cells (35±8%) and total CFC (44 ± 6%) ( Figure 1d , right panel). Similar to bone marrow, total CFC in the spleen of Tamoxifen-treated Cre ER -Survivin fl/fl mice was decreased by 62±12% ( Figure 1e ).
To further evaluate the functional role of Survivin in HSC regulation, we performed long-term competitive repopulating assays. Lethally irradiated C57Bl/6 mice were transplanted with 1 Â 10 6 cells consisting of congenic B6.BoyJ (CD45.1) marrow cells plus marrow cells (CD45. Supplementary Figures 1A and B ) as previously described. 17 Analysis of T, B and myeloid cells in peripheral blood showed equal reduction in all lineages (Figure 1f , right panel). In addition to reduced contribution to chimerism, the absolute number of Survivin gene-deleted donor-derived CD34 neg KSL cells in the recipient mice marrow 20 weeks post transplant (16 weeks post polyI:polyC treatment) was also significantly lower compared with donor cells derived from Survivin fl/fl control mice ( Figure 1g ). These data confirm a significant role for Survivin in regulation of hematopoiesis, indicating that it is essential for HSC maintenance and function. 
Survivin modulates the expression of genes associated with divergent molecular functions in mouse HSCs
To identify downstream pathways regulated by Survivin in HSCs, mRNA expression in FACS-sorted CD34 neg KSL cells before and after Survivin deletion were compared using cDNA microarrays. In two separate experiments, we found 1653 transcripts that were differentially regulated in CD34 neg KSL cells upon Survivin deletion, 965 downregulated and 688 upregulated. The full list of Survivin-regulated genes has been deposited in the public domain. Birc5 (Survivin) mRNA was reduced by an average 10.4 ± 0.2-fold (Po0.001), confirming the efficacy of Survivin deletion. Significantly regulated genes (4/o twofold) were classified into 35 clusters according to the Gene Ontology Database (Figure 2a ). The 11 functional categories containing the greatest number of genes among the 35 groups are boxed (Figure 2a ) and shown separately in Figure 2b . The circles in Figure 2 indicate individual functions, and the lines between functional groups represent the presence of shared genes. Survivin disruption altered the expression of genes regulating cell cycle and cell division, as expected based on the known mechanism of action studies (shown with asterisks in Figure 2a ). However, analysis of gene functional categories revealed that Survivin deletion also affected the expression of genes associated with transcription, protein localization, translation, nucleotide binding and RNA processing, functions not previously linked to Survivin activity (Figures 2a and b) .
Comparison of our microarray data with the list of previously reported mouse HSC-associated genes 26 identified a number of these genes that were differentially modulated by Survivin depletion (Figure 2c ). Expression of several transcription factors associated with embryogenesis, hematopoiesis and cell-fate determination, including the homeobox transcription factors HoxA5 and Hoxb1, HIF1a, Evi-1, Foxc1, Pbx1, Gata2 and Sall2, was altered as a consequence of Survivin deletion in CD34 neg KSL cells. To validate the microarray data, quantitative RT-PCR analysis was performed on pairs of CD34 neg KSL cells from Survivin fl/fl and Cre ER -Survivin fl/fl mice ( Table 2) following Survivin deletion. An 8.5-fold reduction in Evi-1 transcripts as well as transcripts of several downstream Evi-1 target genes was observed, including Gata2, which regulates HSC proliferation/ self-renewal, 27, 28 Pbx1, 29 which maintains HSC quiescence 30 and Sall2, which affects committed myeloid progenitor cell differentiation and myeloid cell maturation. 31, 32 The Foxc1 transcript was upregulated by Survivin deletion, consistent with a reported inverse relationship with Pbx1. 33 In addition to the fact that Gata2, Pbx1 and Sall2 are transcriptional targets of Evi-1, analysis of genes in the public mouse KSL cell gene expression database (GSE 2031, www.ncbi.nlm.nih.gov/geo) 34 showed a strong correlation between Survivin (Birc5) and Evi-1(r ¼ 0.35, N ¼ 44, Po0.05), and similar to mouse HSCs, Survivin showed a positive correlation (r ¼ 78) with Evi-1 in highly purified human HSCs (Gene expression Omnibus: www.ncbi.nlm.nih.gov/geo). 35 Survivin regulates HSC function through Evi-1 Differential expression of transcription factors upon Survivin deletion was an unexpected result, as a direct role for Survivin in regulating mammalian gene transcription has not been reported. However, Bir1, the Caenorhabditis elegans homolog of Survivin, can function as a transcriptional regulator 36 and Survivin has been shown to affect the expression of multiple genes in cancer cells. [37] [38] [39] As a strong correlation was seen between Survivin deletion and reduction in Evi-1 as well as Evi-1 downstream targets genes, we focused on evaluating a potential Survivin/Evi-1 functional axis in regulating HSC function. We hypothesized that restoration of Evi-1 signaling in HSCs would restore or protect impaired hematopoiesis resulting from Survivin deletion. Survivin deletion in bone marrow cells from Cre ER -Survivin fl/fl mice transduced with retroviruses containing MSCV (Murine Stem Cell Virus) vector resulted in an almost total reduction in the number of KSL cells (Figure 3a , top) and CD34 neg KSL cells (Figure 3a , bottom; Survivin þ / þ vector (bar 1) vs Survivin À / À vector (bar 3)). In contrast, significantly more KSL and CD34 neg KSL cells were observed when Survivin was deleted in bone marrow cells ectopically expressing Evi-1 (Figure 3 , N ¼ 3, Po0.05; Survivin À / À vector (bar 3) vs Survivin À / À Evi-1 (bar 4)). The enhancing effect of ectopic Evi-1 in Survivin-deleted bone marrow cells was not observed in control Survivin fl/fl bone marrow cells (Survivin þ / þ vector (bar 1) vs Survivin þ / þ Evi-1 (bar 2)).
Next, marrow cells from Survivin fl/fl or Mx1-Cre Survivin fl/fl mice (CD45.2) were transduced with MSCV vector or human Evi-1 cDNA and subsequently transplanted along with competitor marrow cells (CD45.1) into lethally irradiated congenic mice. At 8 weeks post transplantation before induction of Survivin gene deletion, there were no significant differences in peripheral blood chimerism between Evi-1 and vector control treatments (Figure 3b , top panel). (Figure 3b , bottom, Survivin þ / þ (bar 1) vs Survivin À / À (bar 2)). In contrast, significantly higher chimerism was observed for donor cells lacking Survivin but expressing ectopic Evi-1, compared with Survivin-deleted cells (Figure 3b , Survivin À / À vector (bar 2) vs Survivin À / À Evi-1 (bar 3) ). The competitive repopulating units of the donor cells expressing Evi-1 was elevated by 17 ± 2-fold in comparison with cells lacking Survivin and without Evi-1 (Po0.0001). None of the recipient mice developed signs of leukemia or died during a 6-month follow-up period. NM_029269  NM_010068  NM_008791  NM_009395  AK012459  NM_008592  NM_008266  NM_016674  NM_013822  NM_010142  NM_133211  NM_010431  NM_007549  BC043297  NM_028042  NM_015772  NM_019654  NM_009765  NM_010909  NM_008163  NM_009812  NM_011587  NM_013641  NM_007963  NM_007901  NM_011161  NM_007913  NM_007589  NM_008258  NM_028783  NM_009656  NM_010736  NM_011171  NM_009689  NM_010453  NM_008090  NM_019641  AK144446   Srgap1  SPP2  Dnmt3b  Pcp4  Tnfaip1  Brf2  Foxc1  Hoxb1  Cldn1  Jag1  Ephb2  Tlr7  Hif1α  Blk  neil1  Ckn1  Sall2  Socs5  Brca2  Nfkbl1  Grb2  Casp8  Tie1  ptger1  Evi1  Edg1  Mapk11  EGR1  calm2  Hn1  Robo4  Aldh2 Ltbr Procr Hoxa5 Gata2 stmn1 Pbx1
Birc5 Figure 2 . Functional gene networks regulated by Survivin in mouse CD34 neg KSL cells. (a) Genes significantly regulated by Survivin in three independent microarray analyses (Po0.05) were functionally classified according to the biological process and molecular function listed in the Gene Ontology database, and the analysis was performed using DAVID software 20 and visualized using the Cytoscape program. 21 Genes for which annotations could not be assigned were excluded. A circle (node) indicates individual functions, and the line (edge) indicates the presence of shared genes between each functional group. Functional categories are boxed and also shown in (b). Asterisks indicate functions related to the cell cycle and cell division for which Survivin has been implicated. (b) The 11 functional categories containing the greatest number of genes among the 35 groups are shown. The size of each circle represents the number of genes involved in each functional category, and the thickness of the line indicates the number of genes shared between given functions. Green or yellow circles represent functions defined by biological process or molecular function, respectively. (c) Heat map for mouse HSC-specific genes 26 found to be differentially modulated by Survivin depletion in CD34 neg KSL cells.
DISCUSSION
Survivin is expressed during development and elevated re-expression is a hallmark of neoplastic cells, associated with neoplastic growth, high proliferative index and resistance to chemotherapy. 1, 2 Increasing evidence also indicates that Survivin plays physiological roles in normal cell division, including hematopoiesis, 3 but little is known regarding signaling or functional pathways through which Survivin regulates normal cell growth. Although we have previously shown that Survivin is expressed in normal human CD34 þ stem and progenitor cells and is required for cell cycle entry and progression and survival, 7, 22, 23 and others have demonstrated that conditional gene deletion in mice alters steady-state hematopoiesis, 17 a direct functional role in HSCs and its downstream mechanistic targets have not been identified.
Although basal Survivin expression is low in mouse HSCs compared with less quiescent hematopoietic populations, as we previously described for human HSCs, 7,23 the catastrophic effect of Survivin deletion became highly notable upon HSC stress because of transplantation. This suggests that Survivin activity or molecular networks that associate with Survivin in HSCs critically modulate HSC fate/function. We now demonstrate that Survivin is essential for normal long-term repopulating HSC function and identify differentially expressed genes associated with HSC function, as well as a number of biological pathways not previously linked to Survivin activity. Surprisingly, Survivin deletion significantly downregulated the expression of Evi-1, a transcriptional factor selectively expressed in HSCs and indispensable for HSC function. 40 Overexpression of Evi-1 in HSCs compensated for the impaired HSC function caused by Survivin deletion.
Conditional Evi-1 knockdown in mice has been shown to reduce marrow KSL and CD34 neg KSL cells without affecting differentiation of mature blood cells. 31 We also observed marginal but significant reduction in platelets in both the Evi-1 31 and Survivin conditional knockout mice ( Table 2 ). The embryonic lethality of Survivin knockout mice is also consistent with the Evi-1 phenotype. 41 These findings suggest that Survivin regulates hematopoiesis similarly to Evi-1. In addition to Evi-1, Survivin knockdown reduced the expression of Gata2, Pbx1 and Sall2 in HSCs that are transactivated by Evi-1 and necessary for normal hematopoietic function. 31 The shared regulation of these genes by Evi-1 and Survivin is consistent with the reduction of Evi-1 expression following Survivin deletion. In contrast, Evi-1 deletion had no effect on Survivin expression in mouse HSCs 31 (GSE 11557), suggesting Survivin is upstream of Evi-1. Importantly, marrow cells derived from conditional Survivin À / À mice expressing ectopic Evi-1 showed significantly enhanced numbers of CD34 neg KSL cells and competitive repopulating activity in comparison with cells in which Survivin was ablated without Evi-1 expression, indicating that Survivin regulates HSC function at least in part through modulation of Evi-1 and that repression of Evi-1 expression is not secondary to the cell cycle alteration and/or apoptosis resulting from Survivin ablation in HSCs.
Ectopic expression of Evi-1 only partially rescued the hematopoietic deficits caused by Survivin deletion, suggesting that Evi-1 is necessary but not sufficient for full Survivin activity. Evi-1 can repress transcription of PTEN (phosphatase and tensin homolog) that regulates HSC function 42 and correlates with Survivin expression in CD34 þ CD38 À cells in patients with acute myeloid leukemia. 43 Our microarray data showed that Survivin deletion upregulated PTEN mRNA expression by B1.4-3.0 fold, but it did not reach statistical significance. Despite the parallel change in Gata2 expression following Survivin deletion, ectopic Gata2 failed to compensate for the hematopoietic defects impaired by Survivin deletion (not shown). However, this is consistent with previous reports showing that the forced expression of Gata2 blocks hematopoiesis. 44 Recent studies indicate that Survivin regulates not only cell division/cell cycle but also intracellular signaling. 45 Our microarray data suggest that Survivin affects multiple signaling pathways including transcription, protein localization and translation in CD34 neg KSL cells. Although some gene alterations may represent changes in cell cycle and/or apoptosis upon Survivin deletion, these findings support the concept that Survivin is involved in divergent HSC cellular functions. Functional grouping informatics analysis revealed that genes associated with transcription were significantly enriched among those regulated by Survivin. Although there is no evidence that Survivin directly regulates gene transcription, Bir1, the C. elegans homolog of Survivin, has been shown to regulate transcription, 36 Survivin expression affects transcription in cancer cells [37] [38] [39] and transgenic expression of Survivin alters expression of multiple genes in the bladder. 46 A transcription factor binding analysis revealed several binding sequences for transcriptional factor Sp1 on the 5 0 noncoding region of the mouse Evi-1 gene (GRCm38.p2 C57BL/6J; NC_00069). Survivin has been shown to modulate DNA binding activity of Sp1 by enhancing its phosphorylation. 37 These findings suggest that Sp1 may be involved in the transcriptional regulation of Evi-1 expression by Survivin.
A previous report has indicated that induced Survivin deletion in Mx1-Cre Survivin fl/fl mice led to bone marrow ablation, loss of hematopoietic stem and progenitor cells and rapid mortality. 17 Although we observed a significant reduction in CD34 neg KSL cells in conditional Cre ER -Survivin fl/fl mice, all mice survived for at least 6 months. This difference may relate to either the incomplete deletion of the Survivin gene by Tamoxifen or to strain differences. Abbreviations: HSC, hematopoietic stem cell; ND, not determined; RT-PCR, reverse transcriptase-PCR. Selected genes whose expression was affected by Survivin deletion in mouse CD34 neg KSL cells. Microarray data represent the average of three independent experiments, and the fold change is shown. Quantitative RT-PCR data are the average for three separate experiments using the DDCt method with the fold change compared with HPRT (Po0.05).
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Alternatively, the induction of interferons, which are known inhibitors of hematopoiesis, 47, 48 by treatment with polyI:polyC 49, 50 in vivo may have synergistically inhibited HSCs in the previous study. 17 Nevertheless, although the effect of Survivin gene deletion was not identical, both model systems clearly demonstrated the catastrophic consequences of Survivin deletion on HSC function. In summary, Survivin regulates HSC proliferation through Evi-1. In addition to Evi-1, genes associated with transcription, cell cycle and those with divergent functions may function as effectors of Survivin activity in HSCs. Presently, it is not clear whether Survivin regulates genes differentially in normal versus leukemic HSCs. This could highlight beneficial pathways for treatments aimed to protect normal HSCs and therapeutically leukemic HSCs. 
